How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Large Volume Parenteral Non-PVC Bag Market
- By Material Composition: Polyolefin Bags, Ethylene Vinyl Acetate (EVA) Bags, Non-PVC Copolymer Bags, Polyethylene Bags
- By Bag Volume Capacity: 500 mL Bags, 1000 mL Bags, 2000 mL Bags, 3000 mL Bags, 4000 mL Bags
- By Application: Intravenous Fluids, Parenteral Nutrition, Blood and Blood Components, Pharmaceutical Drug Delivery, Chemotherapy
- By Closure Type: Spike Port, Luer Lock Port, Screw Cap, Needleless Access Port
- By Sterilization Method: Gamma Irradiation, Ethylene Oxide (EtO) Sterilization, Electron Beam Sterilization
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polyolefin Bags leads By Material Composition at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Large Volume Parenteral Non-PVC Bag Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Material Composition 4
Bag Volume Capacity 5
Application 5
Closure Type 4
Sterilization Method 3
Companies profiled
Baxter International Inc.
B. Braun Melsungen AG
Fresenius Kabi
Nipro Corporation
Terumo Corporation
Nexgen Medical Systems Pvt. Ltd.
Sino Biopharmaceutical Limited
Sagent Pharmaceuticals Inc.
Hospira (a Pfizer company)
Becton
Dickinson and Company (BD)
Sino Medical Sciences Technology Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Fresenius Kabi
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nexgen Medical Systems Pvt. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sino Biopharmaceutical Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Sagent Pharmaceuticals Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hospira (a Pfizer company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Becton
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sino Medical Sciences Technology Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Jiangsu Hengrui Medicine Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Jiangxi Jimin Kexin Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Shandong Weigao Group Medical Polymer Company Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,837M by 2033 · 7.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polyolefin Bags52.7
- Ethylene Vinyl Acetate (EVA) Bags15.4
- Non-PVC Copolymer Bags18.1
- Polyethylene Bags13.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,781M → $3,096M · 7.2%
Europe$1,241M → $2,513M · 9.2%
Asia Pacific$1,133M → $2,078M · 7.9%
Latin America$701.4M → $1,404M · 9.1%
Middle East and Africa$539.6M → $899.3M · 6.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.752026
7.762027
7.762028
7.782029
7.802030
7.802031
7.812032
7.832033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Baxter International Inc.30.7
- B. Braun Melsungen AG11.8
- Fresenius Kabi10.2
- Nipro Corporation6.0
- Terumo Corporation7.8
- Nexgen Medical Systems Pvt. Ltd.5.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Composition20.7%
Bag Volume Capacity16.2%
Application27.0%
Closure Type23.9%
Sterilization Method12.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.0
- Europe25.2
- Asia Pacific20.8
- Latin America14.1
- Middle East and Africa9.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Baxter International Inc. | 74 | 75 | 82 | 99 | 86 | 86 | 84 |
| B. Braun Melsungen AG | 88 | 70 | 76 | 83 | 86 | 76 | 80 |
| Fresenius Kabi | 69 | 86 | 85 | 71 | 64 | 67 | 74 |
| Nipro Corporation | 71 | 75 | 72 | 62 | 57 | 79 | 69 |
| Terumo Corporation | 57 | 70 | 53 | 66 | 52 | 63 | 60 |
| Nexgen Medical Systems Pvt. Ltd. | 49 | 69 | 48 | 65 | 58 | 58 | 58 |
| Sino Biopharmaceutical Limited | 62 | 45 | 47 | 56 | 40 | 65 | 53 |
| Sagent Pharmaceuticals Inc. | 60 | 51 | 56 | 53 | 44 | 37 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Kabi
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Baxter International Inc. | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| B. Braun Melsungen AG | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Fresenius Kabi | − | ✓ | ✓ | ◐ | ◐ | ◐ |
| Nipro Corporation | ✓ | − | ◐ | ◐ | − | ✓ |
| Terumo Corporation | − | ✓ | − | ◐ | − | − |
| Nexgen Medical Systems Pvt. Ltd. | − | − | − | ◐ | ◐ | ◐ |
| Sino Biopharmaceutical Limited | ◐ | − | − | − | − | − |
| Sagent Pharmaceuticals Inc. | ✓ | ◐ | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Baxter International Inc.84
2B. Braun Melsungen AG80
3Fresenius Kabi74
4Nipro Corporation69
5Terumo Corporation60
6Nexgen Medical Systems Pvt. Ltd.58
7Sino Biopharmaceutical Limited53
8Sagent Pharmaceuticals Inc.50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Baxter International Inc.B. Braun Melsungen AG
Challenger2
Strong scale, closing on the leaders.
Fresenius KabiNipro Corporation
Contender2
Focused players with pockets of strength.
Terumo CorporationNexgen Medical Systems Pvt. Ltd.
Niche2
Specialists in a single segment or region.
Sino Biopharmaceutical LimitedSagent Pharmaceuticals Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Composition in North America, then scale across Large Volume Parenteral Non-PVC Bag Market — a $221M beachhead inside a $4.34B market.
Beachhead (SOM)$221Mobtainable near-term
Serviceable (SAM)$1.55Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Polyolefin Bags
Best fit — highest urgency & budget in Material Composition.
Economic buyer78 fit
Ethylene Vinyl Acetate (EVA) Bags
Strong fit — clear ROI and a fast path to value.
End user66 fit
Non-PVC Copolymer Bags
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Composition in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Bag Volume Capacity & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Material Composition leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Large Volume Parenteral Non-PVC Bag Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified23%
Evaluation11%
Closed-won6%
$21.9KCAC
$84KLTV
3.8:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Large Volume Parenteral Non-PVC Bag Market is a durable-growth opportunity — $8.51B by 2033, compounding at 6.1%.
TAM · 2025$5.29Btoday
TAM · 2033$8.51Bforecast
CAGR6.1%2027–2033
Cumulative$61.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.51BTotal addressable market
SAM$3.35BServiceable available market
SOM$628MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.1% CAGR
Demand compounds through 2033, outpacing GDP across Material Composition.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Composition moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.51BLarge & growingTAM by 2033 at 6.1% CAGR
$3.35BServiceable nowreachable with today’s model
$628MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.64BBear4.0% CAGR
$8.51BBase6.1% CAGR
$10.9BBull8.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Bag Volume Capacity optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Large Volume Parenteral Non-PVC Bag Market — a $12.1B market by 2033. Plan: grow share from 9.2% to 18.9%.
Market size · 2033$12.1Btotal addressable
Market CAGR11.6%2027–2033
Target share18.9%from 9.2% today
Revenue ambition$2.28Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.2% | 18.9% | On track |
| Revenue | $1.12B | $2.28B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 34.4% | 39.9% | Behind |
| Customer retention | 89.3% | 95.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Composition
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Bag Volume Capacity capability
A defensible second engine — invest in Bag Volume Capacity to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Composition share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Bag Volume Capacity
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $260M capacity & capability investment
- Greenlight bolt-on M&A in Bag Volume Capacity
- Authorise North America expansion plan
- Fund R&D program for Material Composition leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Large Volume Parenteral Non-PVC Bag Market conversation — a $4.35B market you can size, segment and defend in minutes.
Market size · 2033$4.35Btotal opportunity
Growth10.1%CAGR to 2033
Addressable buyers1,047+accounts in scope
Typical ROI6.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Composition
Goal Grow share in Material Composition
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.2×return on cost, year one
< 3 mopayback period
$49K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Baxter International Inc.B. Braun Melsungen AGFresenius KabiNipro CorporationTerumo CorporationNexgen Medical Systems Pvt. Ltd.Sino Biopharmaceutical LimitedSagent Pharmaceuticals Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Large Volume Parenteral Non-PVC Bag Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Large Volume Parenteral Non-PVC Bag Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Large Volume Normal Saline Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportLarge Volume Nebulizer Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportLarge Volume Intravenous Solution Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportLarge Volume Injector Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportLarge Volume Injection Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportLarge Volume Autoinjector Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportLarge Steam Sterilizer Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportLarge Size Surgical Monitor Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportLarge Size Autoclavable Biohazard Bags Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportLarge Scale Oligonucleotide Synthesis Service Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportLarge-scale Medical Imaging Equipment Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportLarge Molecule Bioanalytical Testing Service Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.